Cargando…
Thalidomide for prevention of camrelizumab‐induced reactive cutaneous capillary endothelial proliferation
OBJECTIVES: The study evaluated the efficacy of thalidomide in prevention of camrelizumab‐induced reactive cutaneous capillary endothelial proliferation (RCCEP). METHODS: In this study, patients treated with camrelizumab plus thalidomide or camrelizumab alone were included. The occurrences, onset ti...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313837/ https://www.ncbi.nlm.nih.gov/pubmed/35229882 http://dx.doi.org/10.1111/ajd.13812 |